Pipetting Samples

To date, the Catherine Elizabeth Blair Memorial Foundation has given neuroblastoma research grants totaling over $247,000

 NEUROBLASTOMA RESEARCH

Research Projects

The Catherine Elizabeth Blair Memorial Foundation supports innovative neuroblastoma research in institutions across the US and internationally.  

$100,000 in grants: Advancing Breakthroughs in Neuroblastoma Research and Care: Each year from 2015-2019 we granted $25,000 to Dr. Anthony Sandler's research lab at Children's National in Washington, DC for his work on immune-based tumor vaccine therapy.  

$25,000 Grant: Fully Human Glypican-2 Targeting Bispecifics for the Treatment of Neuroblastoma: In 2018, we granted $25,000 to Dr. Colin Correnti at the Fred Hutchinson Cancer Research Institute in Seattle, with key collaborator Julie Park, MD at Seattle Children's Hospital for an immunotherapy project creating clinic-ready antibodies to be used in future research.  

$20,000 Grant: Phase I/II Clinical Trial for Neuroblastoma with ALK Mutations: In 2016, we granted $20,000 in collaboration with a multi-charity group brought together by Solving Kids' Cancer to open a multi-institution trial of a tumor-inhibiting drug driven by ALK mutations.  

We have collaborated with other neuroblastoma-focused organizations in funding research: the Evan Foundation and Solving Kids' Cancer 

The Catherine Elizabeth Blair Memorial Foundation is a component fund of the Greater Washington Community Foundation.  


All gifts are fully tax deductible under the Community Foundation's 501(c)3 status.

Tax ID # 23-7343119

Get Updates

Quick Links

  • White Facebook Icon
  • White Twitter Icon
  • White Instagram Icon

© 2020 by Blairfoundation.org